Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
530 studies found for:    H1n1 | "Influenza, Human"
Show Display Options
Rank Status Study
1 Completed Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
Conditions: HIV-1 Infection;   H1N1;   Influenza;   Flu
Interventions: Biological: FluMist;   Biological: Fluvirin;   Biological: Fluzone
2 Completed Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon
Conditions: A/H1N1 Influenza;   Swine Flu
Intervention:
3 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
4 Completed Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine
Conditions: Novel Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
5 Completed Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
Conditions: Influenza;   Pandemic Influenza;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: A/H1N1 pandemic influenza vaccine (non- adjuvanted)
6 Completed Influenza A 2009 H1N1 Challenge Study in Healthy Adults
Condition: Influenza, Human
Intervention: Procedure: Virus administration: Influenza A/H1N1 Influenza Challenge Virus, IND#14969
7 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + adjuvant)
8 Completed A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
9 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
10 Completed A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Intervention: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
11 Completed
Has Results
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults
Conditions: Influenza A Virus, H1N1 Subtype;   Influenza Infection
Interventions: Biological: GSK2340274A;   Biological: GSK2340273A;   Biological: Seasonal trivalent influenza vaccine (TIV);   Biological: Saline placebo
12 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine
Conditions: Influenza;   H1N1 2009 Influenza
Intervention: Biological: Arepanrix, Vaxigrip 2009/2010
13 Completed Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults
Conditions: Influenza;   Swine-Origin A/H1N1 Influenza Virus
Intervention:
14 Completed Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants
Conditions: Immunocompromised Patients;   Safety of Pandemic Influenza A (H1N1)Vaccine;   Immunogenicity of Pandemic Influenza A (H1N1)Vaccine
Intervention: Biological: Split inactivated A/California/7/2009 (H1N1) (NYMC X-179A) VIRUS
15 Completed Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
Intervention:
16 Completed Novel Influenza A (H1N1) Surveillance Registry
Conditions: Novel Influenza A;   H1N1;   Influenza
Intervention:
17 Completed Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Conditions: Influenza A Virus, H1N1 Subtype;   Influenza Infection
Intervention: Biological: Pandemic influenza vaccine GSK2340272A
18 Completed Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
Conditions: Pandemic Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
19 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
20 Completed
Has Results
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Condition: Novel 2009 Influenza H1N1
Interventions: Biological: MF59-eH1N1_f;   Biological: eH1N1_f

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years